Results in Fig. 3B showed that more than two times of miR-34a and Bcl-2 expression were altered in the treatment of VV-miR-34a compared with synthetic mimics, which suggests OVV is an ideal expression vector for miR-34a delivery in MM cell lines. This evidence concerns the gene BCL2 and Miyoshi myopathy.